View in EDS HTML Full Text PDF Full Text

Author Correction: DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B.

Saved in:
Bibliographic Details
Title: Author Correction: DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B.
Authors: Lee KW; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. imdoctor@snu.ac.kr., Mahalingam D; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Shim BY; The Catholic University of Korea St. Vincent's Hospital, Suwon, Korea., Kim IH; Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea., Oh DY; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea., Uronis H; Duke University Medical Center, Durham, NC, USA., Sym SJ; Gachon University Gil Medical Center, Incheon, Korea., Sonbol M; Mayo Clinic Hospital, Phoenix, AZ, USA., Almhanna K; Rhode Island Hospital, Brown University Medical Center, Providence, RI, USA., Tejani MA; Advent Health Cancer Institute, Orlando, FL, USA., Kang B; CHA Bundang Medical Center, Seongnam, Korea., Kagey MH; Leap Therapeutics, Cambridge, MA, USA., Stilian M; Leap Therapeutics, Cambridge, MA, USA., Jia C; Leap Therapeutics, Cambridge, MA, USA., Sirard CA; Leap Therapeutics, Cambridge, MA, USA., Altura R; Leap Therapeutics, Cambridge, MA, USA., Ajani JA; MD Anderson Cancer Center, Houston, TX, USA., Klempner SJ; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA. sklempner@mgb.org.
Source: Nature communications [Nat Commun] 2026 Feb 06; Vol. 17 (1), pp. 1437. Date of Electronic Publication: 2026 Feb 06.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41651836
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Lee+KW%22">Lee KW</searchLink>; Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea. imdoctor@snu.ac.kr.<br /><searchLink fieldCode="AU" term="%22Mahalingam+D%22">Mahalingam D</searchLink>; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Shim+BY%22">Shim BY</searchLink>; The Catholic University of Korea St. Vincent's Hospital, Suwon, Korea.<br /><searchLink fieldCode="AU" term="%22Kim+IH%22">Kim IH</searchLink>; Seoul St. Mary's Hospital, The Catholic University of Korea, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Oh+DY%22">Oh DY</searchLink>; Seoul National University Hospital, Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Uronis+H%22">Uronis H</searchLink>; Duke University Medical Center, Durham, NC, USA.<br /><searchLink fieldCode="AU" term="%22Sym+SJ%22">Sym SJ</searchLink>; Gachon University Gil Medical Center, Incheon, Korea.<br /><searchLink fieldCode="AU" term="%22Sonbol+M%22">Sonbol M</searchLink>; Mayo Clinic Hospital, Phoenix, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Almhanna+K%22">Almhanna K</searchLink>; Rhode Island Hospital, Brown University Medical Center, Providence, RI, USA.<br /><searchLink fieldCode="AU" term="%22Tejani+MA%22">Tejani MA</searchLink>; Advent Health Cancer Institute, Orlando, FL, USA.<br /><searchLink fieldCode="AU" term="%22Kang+B%22">Kang B</searchLink>; CHA Bundang Medical Center, Seongnam, Korea.<br /><searchLink fieldCode="AU" term="%22Kagey+MH%22">Kagey MH</searchLink>; Leap Therapeutics, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Stilian+M%22">Stilian M</searchLink>; Leap Therapeutics, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Jia+C%22">Jia C</searchLink>; Leap Therapeutics, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Sirard+CA%22">Sirard CA</searchLink>; Leap Therapeutics, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Altura+R%22">Altura R</searchLink>; Leap Therapeutics, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ajani+JA%22">Ajani JA</searchLink>; MD Anderson Cancer Center, Houston, TX, USA.<br /><searchLink fieldCode="AU" term="%22Klempner+SJ%22">Klempner SJ</searchLink>; Department of Medicine, Division of Hematology-Oncology, Massachusetts General Hospital, Boston, MA, USA. sklempner@mgb.org.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2026 Feb 06; Vol. 17 (1), pp. 1437. <i>Date of Electronic Publication: </i>2026 Feb 06.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; In Process
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41651836
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41467-026-69394-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1437
    Titles:
      – TitleFull: Author Correction: DKN-01 and tislelizumab as second-line therapy in DKK1-high gastroesophageal adenocarcinoma: DisTinGuish trial part B.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Lee KW
      – PersonEntity:
          Name:
            NameFull: Mahalingam D
      – PersonEntity:
          Name:
            NameFull: Shim BY
      – PersonEntity:
          Name:
            NameFull: Kim IH
      – PersonEntity:
          Name:
            NameFull: Oh DY
      – PersonEntity:
          Name:
            NameFull: Uronis H
      – PersonEntity:
          Name:
            NameFull: Sym SJ
      – PersonEntity:
          Name:
            NameFull: Sonbol M
      – PersonEntity:
          Name:
            NameFull: Almhanna K
      – PersonEntity:
          Name:
            NameFull: Tejani MA
      – PersonEntity:
          Name:
            NameFull: Kang B
      – PersonEntity:
          Name:
            NameFull: Kagey MH
      – PersonEntity:
          Name:
            NameFull: Stilian M
      – PersonEntity:
          Name:
            NameFull: Jia C
      – PersonEntity:
          Name:
            NameFull: Sirard CA
      – PersonEntity:
          Name:
            NameFull: Altura R
      – PersonEntity:
          Name:
            NameFull: Ajani JA
      – PersonEntity:
          Name:
            NameFull: Klempner SJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 06
              M: 02
              Text: 2026 Feb 06
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2041-1723
          Numbering:
            – Type: volume
              Value: 17
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Nature communications
              Type: main
ResultId 1